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330Objective: Our objective was to assess the morbidity and mortality in children requiring extracorporeal mem-
brane oxygenator support after cardiac surgery and to determine factors influencing outcome.
Methods: Between January 2003 and June 2008, 58 patients required extracorporeal membrane oxygenator sup-
port after cardiac surgery. A retrospective study was performed and factors influencing outcome were determined
by logistic regressionmodeling with the probability of outcome based on a combination of multivariate predictors.
Results: Median age and weight were 12 days and 3.3 kg, respectively. Thirty-one patients had single ventricle
repair and 27 had biventricular repair. Median duration of support with the oxygenator was 6 days. Thirty-nine
(67%) patients were successfully weaned off the support, but only 24 (41%) survived to hospital discharge. Chief
complications were renal failure (31%), neurologic complications (29%), and sepsis (16%). Multivariable logis-
tic regression analysis identified 10 days ormore of extracorporealmembrane oxygenation (odds ratio¼ 6.1), urine
output less than 2mL $ kg1 $ h1 in first 24 hours (odds ratio¼ 15), renal failure (odds ratio¼ 9.4), and pH less than
7.35 after 24 hours of extracorporeal membrane oxygenation (odds ratio¼ 82) as significant independent factors
associated with failure to wean off extracorporeal membrane oxygenation. Factors associated with failure of hos-
pital discharge despite successful decannulation were as follows: extracorporeal membrane oxygenator support
time of 10 days or more, red blood cell transfusion of greater than 1000 mL/kg during the entire period of oxygen-
ator support, and sepsis. Patients with single ventricle repair were at higher risk of hospital mortality.
Conclusion: Longer duration of extracorporeal membrane oxygenator support, low pH and urine output in the
first 24 hours, and renal failure are significant factors associated with mortality during extracorporeal membrane
oxygenator support. Exposure to high amounts of blood transfusion during extracorporeal oxygenation, extended
extracorporeal membrane oxygenator support, and sepsis increase risk of death after successful decannulation.
(J Thorac Cardiovasc Surg 2010;140:330-6)Supplemental material is available online.
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Since its inception, the use of extracorporeal membrane
oxygenation (ECMO) after cardiopulmonary bypass (CPB)
for correction of congenital heart defects (CHDs) has contin-
ued to steadily increase. However, the average survivals
have remained essentially constant between 35% and
45%1 with a significant rate of complications.1 Despitee Departments of Cardiovascular Surgerya and Critical Care,b Children’s
nal Medical Center, Washington, DC.
res: None.
d for publication Aug 14, 2009; revisions received Jan 17, 2010; accepted for
ation Feb 13, 2010.
for reprints: Achintya Moulick, MD, MBA, Chief Cardiothoracic Surgery, St.
topher’s Hospital for Children, 3601 A St, Philadelphia, PA 19134 (E-mail:
tya1.moulick@tenethealth.com).
23/$36.00
ht  2010 Published by Elsevier Inc. on behalf of The American Association
acic Surgery
016/j.jtcvs.2010.02.034
The Journal of Thoracic and Cardiovascular Surgattempts to identify factors affecting outcome,2-8 there is
no unanimous opinion. The purpose of this study was to
determine factors influencing mortality and morbidity in
patients placed on ECMO after CPB.
PATIENTS AND METHODS
Study Population
Between January 2003 and June 2008, 58 consecutive patients requiring
ECMO after repair of CHDs were retrospectively studied. These 58 patients
represented 4.5% of 1261 cardiac procedures for correction of CHDs at the
Children’s National Medical Center, Washington, DC. The study period in-
volved a number of surgeons and was a stage of transition not only in terms
of operative techniques but also in having an in-house senior fellow avail-
able for cannulation around the clock starting from August 2007. This study
was approved by our institutional review board.
Data were collected from detailed patient charts available in the medical
records department, the ECMO department, and the blood bank. We
included all patients who required ECMO after cardiac surgery during the
index admission regardless of duration from surgery. Four patients had ad-
ditional ECMO runs during the same admission. They were counted only
once and information from the initial operation and first ECMO run was an-
alyzed. Multiple factors (clinical and biochemical) were analyzed for their
impact on survival and morbidity. These factors included those that have
been analyzed in previous studies2-8 and some that we hypothesized
could affect outcome (Table 1 and Table E1).
Inotrope score (Table E2) was calculated using this formula: inotrope
score ¼ dopamine þ dobutamine þ epinephrine þ norepinephrine þ
(milrinone 3 15), all in micrograms per kilogram per minute times 100.7ery c August 2010
Abbreviations and Acronyms
CHD ¼ congenital heart defects
CPB ¼ cardiopulmonary bypass
CPR ¼ cardiopulmonary resuscitation
ECMO ¼ extracorporeal membrane oxygenation
PRBCs ¼ packed red blood cells
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Patients who required ECMO in the operating room owing to failure to
wean from CPBwere cannulated through the right atrium and the ascending
aorta.
A transthoracic route was also generally used for patients requiring emer-
gency ECMO in the intensive care unit in the immediate postoperative pe-
riod (<15 days), whereas peripheral cannulation was used for those in the
later period. The neck vessels were used in patients weighing less than
15 kg; otherwise, the femoral vessels were used. The final decision for
the site of cannulation was left to the discretion of the surgeon.
A standard ECMO circuit consisting of a roller pump head (Jostra; Ma-
quet Inc, Rastatt, Germany) and a membrane oxygenator (Medtronic, Inc,
Minneapolis, Minn) was used. Monitors for pressure before and after
ECMO were used. A disposable heat exchanger was used to maintain con-
stant temperature of the blood in the circuit. The priming volume of the cir-
cuit depended on the surface area of the oxygenator and the patient weight.
In an emergency situation, a rapid ECMO circuit consisting of a hollow fi-
ber oxygenator (Minimax/Affinity; Medtronic, Inc) with a centrifugal pump
head (Bio-Medicus; Medtronic, Inc) was used for quick priming and ease of
deployment. The rapid ECMO circuit was primed with crystalloid unless
blood was immediately available. The circuit required an average priming
volume of 250 mL for an infant. Once the patient was deployed on
ECMO, packed red blood cells (PRBCs) were transfused and the excess
crystalloid removed by a manual exchange transfusion method. This circuit
was replaced within 72 hours with a conventional circuit consisting of a sil-
icone membrane oxygenator as described above unless the ECMO support
was no longer required. The conventional circuit had a larger priming vol-
ume of approximately 500 mL but did not require change unless there were
clots within the system. Every change of circuit thus exposed the patient to
an additional 500 mL of blood in addition to a new surface lining of tubings
and oxygenator. Whenever elective ECMOwas used in the operating room,
separation from CPB and reversal of heparinization were attempted before
institution of ECMO to reduce bleeding. A hematocrit value of greater than
35% was maintained on ECMO with transfusion to a hematocrit value of
45% before discontinuing ECMO, especially in cyanotic patients.
ECMOflows were regulated on the basis of patient variables such as sys-
temic blood pressure, organ perfusion, venous saturations, and serial lactate
measures.When on full flow rates, inotropic support was kept at a minimum,
although most patients continued to receive milrinone throughout their
ECMO course. Vasoactive support was often increased as weaning com-
menced and the cardiac load was increased. Similarly, at full flows, the ven-
tilatory support was minimized and was gradually increased as the ECMO
support was weaned off. The gas flow rate and blender were adjusted on
the ECMO circuit to keep the blood gas values within the normal range.
Fluid input to the patient was adjusted according to the body weight and
other clinical factors like temperature and fluid losses. Ultrafiltration was
performed with a hemofilter (Minntech HPH 400; Minntech, Minneapolis,
Minn) in line with the ECMO circuit to augment fluid removal in cases of
volume overload.Hemodialysis was used in patientswith renal insufficiency
or renal failure. Continuous heparin was infused to maintain activated clot-
ting time between 180 and 200 seconds except when there was excessive
bleeding and a lower activated clotting time was accepted. Platelet countThe Journal of Thoracic and Cawas maintained above 100,000/mL. Daily measurement of prothrombin
time, partial thromboplasin time, and fibrinogens was also performed. Fresh
frozen plasma was administered to maintain normal prothrombin time and
fibrinogen levels and partial thromboplastin time less than 150 seconds.
For patients with single ventricle repair and systemic-to-pulmonary
shunts, we routinely undersized the shunt by applying surgical clips to re-
duce the steal of blood from the systemic circulation instead of increasing
the ECMO flows, a strategy used by other groups.2,9 We empirically
clipped the shunt to 50% of diameter at the time of ECMO deployment,
and further clipping was based on perfusion pressure. These clips were
later removed as the patient was weaned off the ECMO support. A left
atrial vent was used in patients with biventricular repair when there was
evidence of poor decompression of the left side of the heart. Carotid
reconstruction was always attempted in all cases of neck cannulation.
Renal failure was defined as oliguria or anuria with raised creatinine level
(>1.5 mg/100 dL) (Table E2). Neurologic complication was defined as in-
tracranial infarct or hemorrhage, evidence of hypoxic insult, or brain death.
Head ultrasound was used to define intracranial infarct or hemorrhage,
whereas brain death was diagnosed as per the standard accepted criteria.
Head ultrasound was performed every day for the first 3 days and every al-
ternate day or as indicated after that. The use of computed tomographic scan
(portable) and electroencephalography were based on clinical condition and
suspicion of neurologic damage. Sepsis was defined as systemic inflamma-
tory response in the presence of infection (suspected or proven) (Interna-
tional Pediatric Sepsis Consensus Conference, 2005). Patients in whom
severe neurologic damage developed or in whom recovery was deemed
futile by the care team (in consultation with the family) were electively
removed from ECMO support.
Statistical Analysis
Continuous variables are expressed as median and interquartile range
owing to skewness. Kaplan–Meier survival analysis was used to compare
patient outcome on ECMO between subgroups such as pH of 7.35 or
more versus pH less than 7.35 at 24 hours with survival curves compared
by the log–rank test and 95% confidence intervals constructed by the
Greenwood formula.10 Cutoff values chosen were determined in part on
the basis of medians for the entire cohort of 58 patients; however, we did
also review univariate receiver operating characteristic curves and deter-
mined an optimal cutoff value for pH, urine output, and ECMO duration us-
ing the Youden index to maximize sensitivity. Factors associated with death
on ECMO and hospital mortality were evaluated by univariate analysis on
the basis of clinically appropriate cutoff values using logistic regression
analysis and tested by multivariate analysis using a stepwise logistic
model.11 Odds ratios and 95% confidence intervals were calculated for sig-
nificant factors, and probability of death on ECMO (n ¼ 19) and hospital
mortality (n ¼ 34) were derived for combinations of multivariate factors
to provide clinical prediction rules. We limited the number of covariates
in the multivariate data analyses with the rationale of obtaining a more nu-
merically stable model and a set of prognostic variables that is more easily
generalized and less dependent on the observed data.12,13 To validate the
predictive ability of the fitted multivariable models, we used the c-index
to measure how well our logistic regression models predicted outcome,
with a greater c value (maximum 1, c ¼ 0.5 indicating a model with no
discrimination) indicating a greater ability of the model to predict the
outcome, where typically 0.80 or higher reflects excellent predictive
ability.11 Statistical analyses were performed with the SPSS for Windows
software system (version 17.0; SPSS, Inc, Chicago, Ill).RESULTS
Characteristics for the entire cohort of 58 patients
(31 boys, 27 girls) are summarized in Table 1. Median age
and weight were 12 days and 3.3 kg, respectively. Therdiovascular Surgery c Volume 140, Number 2 331
TABLE 1. Characteristics of children undergoing ECMO in study
cohort (n ¼ 58)
Variable
Median value or
No. of patients
Interquartile
range or%
Age at surgery, d 12 4–204
Weight, kg 3.3 2.6–6.2
Gender
Male 31 53
Female 27 47
Race
White 21 36
African American 26 45
Hispanic 9 16
Asian 2 3
Diagnosis
L-R shunt 4 7
Left-sided obstruction 3 5
HLHS 20 34
Cyanotic, increased PBF 5 9
Cyanotic, decreased PBF 15 26
Cyanotic, increased pulmonary
congestion
8 14
Other 3 5
Intraoperative features
CPB time, min 118 85–188
Crossclamp time, min 48 40–65
DHCA, min 28 0– 50
Laboratory values, pre-ECMO
pH level 7.29 7.19–7.42
Serum bicarbonate, mEq/L 24.5 17.2–27.9
Lactate1(mmol/L 4–12 h
pre-ECMO)
4.1 2.8–7.8
Lactate2(mmol/L 0–4 h
pre-ECMO)
7.6 3.4–11.2
Inotrope score—start of ECMO 1050 762–1488
Indication for ECMO
Cardiac arrest 29 50
Failure to wean from bypass 19 33
Low cardiac output 8 14
Hypoxia 2 3
ECMO duration, d 6 3–10
Laboratory values at 24 h
pH level 7.44 7.36–7.50
Lactate, mmol/L 2.2 1.80–3.80
Serum bicarbonate, mEq/L 30.0 27.0–34.4
Urine output, mL $ kg1 $ h first
24 h1
3.30 1.85–6.95
PRBCs, during support, mL/kg 715 440–1117
ECMO, Extracorporeal membrane oxygenation; L-R, left-to-right; HLHS, hypoplastic
left heart syndrome; PBF, pulmonary blood flow; CPB, cardiopulmonary bypass;
DHCA, deep hypothermic circulatory arrest; PRBCs, packed red blood cells.
FIGURE 1. Kaplan–Meier survival curves for patients with pH 7.35 and
those<7.35 at 24 hours. The error bars denote 95% confidence intervals as
determined by the Greenwood formula.
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variety of cardiac lesions. Single ventricle repair was per-
formed in 53%. The major indication for ECMO was car-
diac arrest. Among 58 patients, 19 (33%) died on ECMO.
A total of 34 (59%) patients died in the hospital. A total
of 18 (31%) patients had renal failure and 17 (29%) had332 The Journal of Thoracic and Cardiovascular Surgneurologic complications. Intracranial hemorrhage occurred
in 15 patients; cerebral infarction in 5; and clinical seizures
in 3. Nine (16%) patients had sepsis. Although abnormal
bleeding parameters occurred in many patients, true dissem-
inated intravascular coagulopathy (defined as abnormal pro-
thrombin time, partial thromboplastin time, fibrinogen, and
low platelets) occurred in only 2 patients and could be ulti-
mately controlled with blood products. Four patients re-
quired second ECMO runs. Three of them survived the
second run, too, but died of sepsis, whereas in the fourth pa-
tient, features of multiorgan failure developed on the second
ECMO run and support was discontinued. These 4 patients
were counted among those who survived ECMO but died
before hospital discharge. For purposes of data analysis, in-
formation from only the first ECMO run was used. Compli-
cations during the entire hospital course were included.
We performed 3 sets of univariate and multivariate
analyses to identify prognostic factors that differentiate (1)
survivors from nonsurvivors on ECMO, (2) overall survi-
vors from patients who died in the hospital, and (3) survivors
versus nonsurvivors among children who were weaned from
ECMO.
Seven significant factors associated with death on ECMO
were identified by univariate analysis. Mean pH levels at 24
hours for survivors and nonsurvivors of ECMO were 7.48
and 7.31, respectively (Figure E1). Median survival time
in patients with a pH of 7.35 or more was 27 days versus
only 10 days in patients with a pH less than 7.35 (Figure 1).
Four of the 7 variables associated with failure to wean
from ECMOwere confirmed as independent factors by mul-
tivariable logistic regression analysis (Table 2). In the next
set of analyses, we identified 9 factors associated with hos-
pital mortality by univariate analysis. Of these 9, 5 were con-
firmed as independent risk factors by multivariate logistic
regression analysis, including single ventricle physiology,ery c August 2010
TABLE 2. Factors associated with patient mortality
Factors associated with patient mortality on ECMO
Variable Survived ECMO (n ¼ 39) Died on ECMO (n ¼ 19) Odds ratio (95% CI) Multivariate P value
ECMO time 10 d
Yes 6 (37) 10 (63) 6.1 (1.8–21.4) .005
No 33 (79) 9 (21)
pH<7.35
Yes 1 (7) 13 (93) 82.3 (9.0–750) <.001
No 38 (86) 6 (14)
Urine<2 mL $ kg1 $ h
Yes 4 (25) 12 (75) 15.0 (3.7–60) .012
No 35 (83) 7 (17)
Renal failure
Yes 6 (33) 12 (67) 9.4 (2.7–33.7) <.001
No 33 (83) 7 (17)
Factors associated with hospital mortality
Variable Survivors (n ¼ 24) Nonsurvivors (n ¼ 34) Odds ratio (95% CI) Multivariate P value
Surgical repair
Single ventricle 8 (26) 23 (74) 4.9 (1.6– 14.8) .007
Biventricular 16 (59) 11 (41)
ECMO time 10, d
Yes 1 (6) 15 (94) 18.2 (2.3–150) <.001
No 23 (55) 19 (45)
Lactate>4 mmol/L
Yes 1 (7) 13 (93) 14.2 (2.0–118) <.001
No 23 (52) 21 (48)
Sepsis
Yes 0 (0) 9 (100) ND <.001
No 24 (49) 25 (51)
Renal failure
Yes 2 (11) 16 (89) 9.8 (2.0–48.3) .008
No 22 (55) 18 (45)
Factors associated with mortality for subgroup of patients weaned from ECMO
Variable Survivors (n ¼ 24) Nonsurvivors (n ¼ 15) Odds ratio (95% CI) Multivariate P value
ECMO time 10 d
Yes 1 (17) 5 (83) 11.5 (1.5–112) .02
No 23 (70) 10 (30)
PRBCs>1000 mL/kg
Yes 1 (17) 5 (83) 11.5 (1.5–112) .02
No 23 (70) 10 (30)
Sepsis
Yes 0 (0) 6 (100) ND <.001
No 24 (73) 9 (27)
Percentages are calculated horizontally and shown in parentheses. P values are based on the likelihood ratio test from logistic regression analysis. pH, lactate, and urine output were
measured at 24 hours. ECMO, Extracorporeal membrane oxygenation; CI, confidence interval; PRBCs, packed red blood cells; ND, not determinable because all 9 patients with
sepsis died. Odds ratios and CIs for each factor were estimated from the multivariable analysis.
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constructed probability curves illustrating the relationship
between time in days on ECMO and the probability of hos-
pital mortality for patients with and without renal failure
(Figure E2) and single ventricle versus biventricular repair
(Figure E3 and Table E3).
In the subgroup of 39 patients weaned from ECMO, 3 in-
dependent factors associated with hospital mortality were
identified (ECMO time, amount of PRBCs, and sepsis)The Journal of Thoracic and Ca(Table 2). Sepsis was not included in the multivariable
model because all patients with sepsis died and hence it per-
fectly predicts mortality. However, it is considered a signifi-
cant factor associated with mortality (P< .001).
In as much as the amount of blood transfused was con-
firmed as a multivariate risk factor, we derived the probabil-
ity of hospital mortality as a function of PRBCs transfused
(Figure 2) as a continuous variable adjusted for body weight
(P< .01) and illustrate this relationship.rdiovascular Surgery c Volume 140, Number 2 333
FIGURE 2. Theoretical curve (solid) shows the increasing risk of hospital
mortality with greater blood transfusion (P< .01) among patients weaned
from ECMO. The 95% confidence interval obtained by the logistic regres-
sion model is rather broad (dashed), although clearly indicates higher risk of
death with greater amounts of blood transfused. ECMO, Extracorporeal
membrane oxygenation; PRBC, packed red blood cells.
Congenital Heart Disease Kumar et al
C
H
DResults of computing the c-index for assessing the con-
cordance between the predicted outcomes based on our fitted
multivariable models and the observed outcomes revealed
very strong ability of the models to predict outcome. Refer-
ring to the 3 multivariable models summarized in Table 2,
the c-index value equals 0.981 for predicting mortality on
ECMO based on the 4 significant independent risk factors,
and the c-index value equals 0.958 for hospital mortality
based on 5 risk factors (both analyses are based on all 58 pa-
tients). In addition, the last multivariable model presented in
Table 2, showing the 3 significant risk factors for predicting
failure to be discharged among the 39 patients who were
weaned from ECMO, had a c-index of 0.881, again indicat-
ing excellent predictive ability of the model to predict this
outcome.
During this period, a total of 19 patients who underwent
stage 1 Norwood for hypoplastic left heart syndrome were
placed on ECMO. Of these, 5 patients had a Blalock–Taus-
sig shunt and 14 patients had the Sano modification. Of the 5
patients who underwent a Norwood procedure with the Bla-
lock–Taussig shunt, 4 could not be weaned off ECMO and
only 1 patient survived to discharge. Of the 14 patients
who underwent Norwood with Sano modification, 11 could
be weaned off ECMO. However, of these 11, only 2 patients
survived to hospital discharge. Nevertheless, the Sano shunt
has the important advantage during ECMO that it does not
steal from the perfusion flow and there is no need for clamp-
ing or constriction.
Male gender, site of cannulation (neck), low first 24-hour
urine output, and higher amount of blood transfusion were
significant factors associated with renal failure. In terms of
days from surgery to ECMO, there was a difference between
patients who underwent chest cannulation (median, 1 day;334 The Journal of Thoracic and Cardiovascular Surgrange, 0–17 days) and thosewho underwent neck cannulation
(n¼ 10; median, 12 days; range, 0–65 days; P<.001). Five
of the 10 neck cannulations were done beyond 15 days; 2 of
them after Norwood, 2 after repair of total anomalous pulmo-
nary venous return, and 1 after repair of ventricular septal
defect and coarctation in a patientwith borderline left ventric-
ular function.
Among the 17 (29%) patients who had neurologic com-
plications, the only significant associated factor was a high
lactate level at 24 hours (P ¼ .03). Seven (50%) of the 14
patients with lactate levels greater than 4 mmol/L had neuro-
logic complications, whereas 10 (23%) of the 44 of patients
with lactate levels less than 4 mmol/L had neurologic com-
plications. In the subgroup of 29 patients who required
ECMO for cardiac arrest in our study, the duration of cardio-
pulmonary resuscitation (CPR) was not a risk factor for neu-
rologic complications.
On analyzing the risk factors for sepsis, we found that the
only significant factor was mediastinal re-exploration.
Whereas 7 (27%) of the 26 patients with re-explorations
had sepsis, only 2 (6%) of the 32 without any re-
explorations had sepsis (P ¼ .02).
Half of our patients required ECMO for refractory cardiac
arrest. Among them, the 17 nonsurvivors had higher CPR
time (51  10 minutes) than did the 12 survivors (42  8
minutes; P ¼ .019).
DISCUSSION
Ever since Baffes and associates14 first reported the use of
ECMO after palliative repair of CHD in 1970, it has been
widely used for resuscitation after cardiac operations in chil-
dren. However, there are no widely established criteria gov-
erning its use, partly because of inconsistency of results,2-9
which reflects differences in institutional policy and
spectrum of surgical procedures. Our policy is to use
ECMO as a resuscitative tool for both single and
biventricular repair. This provided us an ideal platform to
test the various factors. Although almost all studies of
ECMO list risk factors for hospital mortality,2-8 we went
further by analyzing risk factors for death on ECMO and
subsequent mortality after decannulation separately. This
has obvious clinical implications.
Consistent with previous studies,2,5,7,8 ECMO duration
was a strong determinant not only of death on ECMO but
also after weaning from ECMO. Longer duration of
extracorporeal bypass has widespread deleterious influence
on the organ systems, including the immune system,15-17
which may contribute to later mortality. Most of our
patients who died after weaning from ECMO died of sepsis
or multiorgan dysfunction. New strategies to reduce the
inflammatory effects of ECMO may reduce these
problems.18,19Albumin and heparin-coated circuits (‘‘biopa-
cification’’) have been proven to reduce the overall inflam-
matory effects by reducing the blood–surface interaction.20ery c August 2010
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have been analyzed as indicators of outcome.6 Similar to the
Boston study,4 pH after 24 hours of ECMO deployment was
predictive of death on ECMO. On the other hand, a lactate
level at 24 hours was more predictive of overall hospital
mortality. In their study, Kolovos and associates6 reported
that lactate levels at 48 hours weremore predictive of a worse
outcome than at 24 hours. Inasmuch as blood flow to the or-
gans is restored by institution of ECMO, abnormal values of
these indicators of tissue perfusion reflect either the overall
hypoperfusion before deployment of ECMO or problems
in oxygen delivery and extraction after deployment of
ECMO. The lactate levels before deployment of ECMO
did not seem to prognosticate the outcome in our study.
Urine output in the first 24 hours of the ECMO run, a surro-
gate marker of organ perfusion, was an independent factor
influencing death on ECMO. This finding is similar to the ex-
perience of the Boston group.4 Again, a low urine output in
the first 24 hours reflects either the ischemic insult to the kid-
neys sustained during the pre-ECMO period or continued or-
gan perfusion abnormalities despite extracorporeal support.
Renal failure was significantly associated with death on
ECMO, and two thirds of the patients in whom renal failure
developed while supported by ECMO died. Renal failure
was also predictive of overall hospital mortality. In our study,
16 of the 18 patients who had renal failure died before dis-
charge despite the use of hemodialysis in all patientswith renal
failure. Renal malfunction has been shown to have an adverse
influence on the various organ systems and significantly
decreases chances of recovery.2-7 We found that male
gender, neck cannulation, low first 24-hour urine output,
and higher amount of blood transfusion were significant
factors associated with renal failure. Although we were
unable to explain male gender as a risk factor, patients who
underwent neck cannulation probably had a longer period of
hypoperfusion (low cardiac output) as they were farther out
from surgical correction. We did not find significant
difference in duration of CPR between the 2 groups. A low
24-hour urine output was predictive of eventual renal failure
and may reflect a greater period of blood flow compromise
to the kidneys occurring either before or after placement on
ECMO. The relation between blood transfusion and end-
organ damage including kidneys is widely established.21
Similar to previous studies,6,7 biventricular repair was
associated with a better survival after ECMO.
Neurologic complications were not an independent indi-
cator of mortality, although they represented a source of
great morbidity. The only significant risk factor was a high
lactate level at 24 hours (P ¼ .03). The duration of CPR
was not a risk factor for neurologic complications. Interest-
ingly, a recent study by the Western Canadian Complex Pe-
diatric Therapies Program Follow-up Group22 showed that
the time for lactate to normalize on ECMO was a risk factor
for poor mental score at 2 years’ follow up. Moreover, theyThe Journal of Thoracic and Cacould not find any association between CPR duration and
mental score at follow-up. Although both of these were
long-term findings compared with the short-term in-hospital
neurologic outcomes reported here, the concurrence of
indicators of neurologic outcome, that is, lactate level
and duration of CPR, is a significant finding that requires
further validation in larger patient series. The incidence of
neurologic complications was independent of the site of
cannulation in our analysis, which is similar to other experi-
ences.4
Sepsis has been shown to have a negative outcome on pa-
tients treated with ECMO in the past.23 Sepsis is generally
a later complication, especially in patients on prolonged
ECMO support. Hence it is not surprising that it was a better
predictor of mortality after successful weaning from ECMO.
In our study, no patient inwhom sepsis developed survived to
hospital discharge. Mediastinal re-exploration was the only
risk factor for sepsis. A greater amount of PRBC transfusion
during the ECMO run had a definite negative effect on the pa-
tient survival despite the fact that the patient was able to be
weaned from ECMO support. Recent studies have linked
bleeding and hence exposure to increased blood volume as
a risk factor for hospital mortality after ECMO.5 Blood trans-
fusion has been shown to be associated with increased inci-
dence of infections.24 It is not surprising that most of the
later deathswere due to sepsis,which could be directly related
to the detrimental effects of ECMO15-17 and blood on the
immune system. The strategy of rapid ECMO circuit
followed by a conventional circuit, often more than once,
exposed the patient to a staggering amount of blood
volume. This is in addition to any blood replacement that
the patient received for bleeding because of either surgical
causes or coagulopathy. One should also not discount the
hemolysis that occurs especially with the centrifugal pump.
Better ECMO circuit designs that do not require change,
reversal of heparinization even for a short time before
deployment of ECMO, meticulous surgical hemostasis, and
cell salvage can all help reduce the amount of blood
exposure. Of late, we have started using the Quadrox
oxygenator (Jostra; Maquet). This is a polymethylpentene
hollow fiber oxygenator that has a smaller priming volume
and is also long-lasting, unlike the previous hollow fiber
membrane oxygenator. Thus, once used on the rapid
ECMO circuit, it does not require a change; hence exposure
to blood is much less. It is hoped that miniaturization of
ECMO circuits25 in the future will reduce not only the prim-
ing volume but also blood contact with artificial surfaces.
The anatomic diagnosis or indication for ECMO, includ-
ing cardiac arrest, did not make any difference in the survival
in our study. Half of our patients required ECMO for refrac-
tory cardiac arrest. The duration of CPRmade a difference in
overall survival within this group, although it did not affect
neurologic outcome. Inotrope score has been evaluated in
the past as a predictor of outcome. We did not find anyrdiovascular Surgery c Volume 140, Number 2 335
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initiation and the outcome. This is similar to other studies.2,7Study Limitations
In our study, hemodynamic variables, ventilatory parame-
ters, or arrhythmias onECMOwere not analyzed.Despite the
good predictive performance of our multivariable models,
we agree that the 95% confidence intervals are wide, owing
to rather small sample size. Despite our efforts to conduct rig-
orous statistical analysis to determine predictors of outcome,
the nature of the study is retrospective and this raises poten-
tial issues regarding possible confounding or bias, which are
concerns for all retrospective cohort studies. A major limita-
tion of such a retrospective cohort design is that collection of
variables is not under the control of investigator and therefore
variables that could have had an important influence on out-
come may not be available for analysis. We also did not an-
alyze outcomes after hospital discharge, including long-term
mortality or possible neurologic complications.22 Finally,
this report details patient outcome from a single center. Inas-
much as centers may have varying surgical approaches and
ECMO management protocols, it is difficult to generalize
these findings without further evaluation of large numbers
of patients in a multicenter fashion.
CONCLUSION
Although ECMO provides effective mechanical support
after cardiac operations in children, mortality and complica-
tion rates are high. Its use must be tempered with the recog-
nition of factors that predict poor outcome. This is all the
more important with rising medical care costs and the heavy
resource use that ECMO currently entails. Prolonged dura-
tion of ECMO support, renal failure, and markers of poor tis-
sue perfusion at the end of first 24 hours of support are
factors influencing mortality on ECMO. Patients who have
undergone single ventricle repair are at increased risk of hos-
pital mortality. Exposure to high amounts of blood transfu-
sion while on ECMO, long duration of ECMO support, and
sepsis all increase the risk of death in patients even after suc-
cessful decannulation. Better strategies are needed for im-
proving patient outcomes.
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FIGURE E1. Scatter plot showing the actual pH values at 24 hours for
each patient segregated by survival or death on ECMO. The mean pH
was 7.48 for survivors and 7.31 for nonsurvivors (P< .001) as shown by
horizontal lines. The triangles below pH of 7.35 are denoted in black.
ECMO, Extracorporeal membrane oxygenation.
FIGURE E3. Results of multivariate logistic regression analysis illustrat-
ing the probability of hospital mortality according to time on ECMO and
type of surgical repair. ECMO, Extracorporeal membrane oxygenation.
FIGURE E2. Results of multivariate logistic regression analysis illustrat-
ing the probability of hospital mortality according to ECMO duration and
presence or absence of renal failure. ECMO, Extracorporeal membrane ox-
ygenation.
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TABLE E1. Clinical variables evaluated for influence on outcome
Pre-support variables
Demographic factors
 Age
 Weight
 Gender
 Ethnicity
Intraoperative features
 Cardiac diagnosis
 CPB time
 Crossclamp time
 Circulatory arrest time
Arterial blood gas values
 pH
 Serum bicarbonate.
 Lactate 1 (4–12 hours before placement on ECMO)
 Lactate 2 (0–4 hours before placement on ECMO)
Inotropes
 Dopamine
 Epinephrine
 Milrinone
 Congenital heart disease type
 Cardiac physiology after surgery
 Indication for ECMO
 Duration of CPR
 Cannulation site
Post-support variables
Arterial blood gas values at 24 hours of support
 pH
 Serum bicarbonate
 Lactate
 Urine output over the first 24 hours of support
Blood product transfusions during suppor.
 Packed RBCs
 Fresh frozen plasma
 Cryoprecipitate
 Platelet
 Mediastinal re-exploration
 Duration of the ECMO
Evidence of organ damage
 Pulmonary
 GI system
 Renal
 Neurologic
 Infectious
 Bleeding.
CPB,Cardiopulmonary bypass;CPR, cardiopulmonary resuscitation; RBCs, red blood
cells; GI, gastrointestinal.
TABLE E2. Classification of patients and definition of complications
Inotrope score ¼dopamineþdobutamineþepinephrine
þnorepinephrineþ (milrinone 3 15) all in mg $ kg1 $ min1 3 100
Diagnosis of congenital cardiac disease
1. Left-to-right shunt
2. Left-sided obstruction
3. Hypoplastic left heart syndrome
4. Right-sided obstruction
5. Cyanosis with increased pulmonary blood flow
6. Cyanosis with decreased pulmonary blood flow
7. Cyanosis with increased pulmonary congestion
8. Other
Cardiac physiology at the time of deployment of ECMO
1. Single ventricle physiology
2. Biventricular physiology
Indications for ECMO deployment
1. Failure of the patient to come off cardiopulmonary bypass
2. Cardiac arrest in the postoperative period
3. Persistent low cardiac output in the postoperative period
4. Hypoxia
Renal failure: oliguria or anuria with raised creatinine level (>1.5 mg/dL)
requiring hemodialysis
Neurologic complication: intracranial infarct or hemorrhage, evidence of
hypoxic insult or brain death
Sepsis: systemic inflammatory response in the presence of infection
(suspected or proven) (as defined by International Pediatric Sepsis
Consensus Conference, 2005)
Gastrointestinal complication: distended abdomen with absent bowel
sounds or abnormal bowel gas pattern or blood in stool
Pulmonary complication: lung collapse, consolidation or any other
process like haemorrhage significant enough to interfere with gaseous
exchange
Dissiminated intravascular coagulopathy: decreased platelet count that
was unresponsive to transfusion, raised activated clotting time in spite of
decreasing heparin, elevated prothrombin time and bleeding from
surgical sites
TABLE E3. Outcome based on type of repair
Single ventricle
repair (n ¼ 31)
Biventricular
repair (n ¼ 27)
Death on ECMO 13 (42%) 6 (22%)
Death after weaning from
ECMO and before hospital
discharge
10 (32%) 5 (19%)
Discharge from hospital 8 (26%) 16 (59%)
ECMO, Extracorporeal membrane oxygenation.
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